Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Operating Expenses | 414 | 431 | 418 | 474 | 580 |
| Operating Income | -414 | -431 | -418 | -474 | -580 |
| Interest Expense | 183 | 70 | 71 | 81 | 40 |
| Other Income | -31 | 31 | 12 | 15 | -54 |
| Pre-tax Income | -628 | -470 | -477 | -540 | -674 |
| Net Income Continuous | -628 | -470 | -477 | -540 | -674 |
| Net Income | $-628 | $-470 | $-477 | $-540 | $-674 |
| EPS Basic Total Ops | -1.61 | -1.20 | -1.20 | -1.40 | -1.70 |
| EPS Basic Continuous Ops | -1.57 | -1.21 | -1.23 | -1.40 | -1.75 |
| EPS Diluted Total Ops | -1.61 | -1.20 | -1.20 | -1.40 | -1.70 |
| EPS Diluted Continuous Ops | -1.57 | -1.21 | -1.23 | -1.40 | -1.75 |
| EBITDA(a) | $-321 | $-397 | $-382 | $-421 | $-580 |